2/19/2014 8:44:22 AM
PETALUMA, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today announced a regulatory approval in Mexico for the company's new Microcyn60® Oral Care family of products intended for use as an adjunct treatment in both mouth and throat infections.
Help employers find you! Check out all the jobs and post your resume.
comments powered by